Novo Nordisk to Introduce Ozempic in India This Month
Danish pharmaceutical giant Novo Nordisk (NOVOb.CO) is preparing to roll out its diabetes medication Ozempic in India within the next…
Wegovy
Read More
Eli Lilly Bets Big on India’s Weight-Loss Market, IMA Warns of Drug Misuse
US pharma giant Eli Lilly is preparing to expand its footprint in India’s fast-growing weight-loss drug market. After launching its…
Eli Lilly’s Mounjaro Overtakes Novo Nordisk’s Wegovy in UK Market Leadership
Eli Lilly’s Mounjaro has emerged as the leading choice in the UK’s private obesity drug market, outperforming Novo Nordisk’s Wegovy…
Eli Lilly Prepares to Launch Obesity and Diabetes Drug Tirzepatide in India by 2025
Eli Lilly, the U.S.-based pharmaceutical giant, plans to introduce its obesity and diabetes drug Tirzepatide (marketed as Mounjaro) in India…
Novo Nordisk India Urges Early Wegovy Launch Amid Competition Concerns
Novo Nordisk’s team in India is asking the company’s global leaders to launch its weight-loss drug Wegovy earlier than planned….
Ozempic and Wegovy Linked to Rare Eye Condition Resulting in One-Eye Blindness
A recent study has identified a potential link between the popular diabetes and weight-loss drugs Ozempic and Wegovy and a…